Kathleen I. Pishas
Papers
1
Total Citations
13
H-Index
1
About
Dr. Kathleen I. Pishas is a leading translational researcher whose work focuses on the molecular underpinnings and therapeutic vulnerabilities of rare, treatment-resistant gynecologic malignancies. Her primary research areas include low-grade serous ovarian carcinoma (LGSOC) and uterine leiomyosarcoma, where she employs high-throughput drug screening and functional genomics to identify novel treatment strategies. Dr. Pishas’s most impactful contribution is her 2024 study on high-throughput drug screening for LGSOC, which uncovered promising therapeutics tailored to this rare cancer’s unique molecular profile—a critical advance given that LGSOC is often excluded from large clinical trials for epithelial ovarian cancer. This work has already garnered 13 citations and is shaping preclinical and clinical efforts to improve outcomes for patients with limited options. Beyond this, she has made significant strides in understanding the role of the tumor microenvironment and DNA repair pathways in sarcoma biology. Her research is distinguished by its direct translational potential, bridging laboratory discoveries to clinical application. Dr. Pishas’s dedication to rare cancers has established her as a key voice in precision oncology, inspiring students and clinicians alike to tackle the most challenging malignancies with innovative, patient-centered approaches.
Research Focus
Key Achievements
Top Papers
- 1